Cloning, characterisation and identification of several polymorphisms in the promoter region of the human α2B-adrenergic receptor gene

Biochemical Pharmacology

Volumn 67, Issue 3, 2004, Pages 469-478

  Cayla, Cécile ^a   Heinonen, Paula ^b   Viikari, Liisa ^b   Schaak, Stéphane ^a   Snapir, Amir ^b   Bouloumié, Anne ^a   Karvonen, Matti K ^b   Pesonen, Ullamari ^b   Scheinin, Mika ^b   Paris, Hervé ^a  

^a CHU RANGUEIL   (France)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Adrenergic receptor; Catecholamine; Polymorphism; Promoter; 2C2

Indexed keywords

ALPHA 2B ADRENERGIC RECEPTOR; AMINO ACID; GENOMIC DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MITHRAMYCIN; NUCLEIC ACID BASE; NUCLEOTIDE; STAT6 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR OLF 1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BASE PAIRING; BINDING SITE; CELL LINE; CELL STRAIN BHK; CONTROLLED STUDY; DNA FLANKING REGION; DNA LIBRARY; DNA POLYMORPHISM; DNA SEQUENCE; ENZYME ACTIVITY; FEMALE; GENE; GENE DELETION; GENE INSERTION; GENE ISOLATION; GENE LOCATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC LINKAGE; GENETIC SCREENING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HELA CELL; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYADENYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; START CODON; TATA BOX;

EID: 10744222082     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.09.029     Document Type: Article

References (30)

1. 2-adrenoceptor subtypes. Annu. Rev. Pharmacol. Toxicol. 33:1993;243-279.
2. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo R.R., Trendelenburg U. International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol. Rev. 46:1994;121-136.
3. Limbird L.E. Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms. FASEB J. 2:1988;2686-2695.
4. 2-adrenergic receptors does not require agonist-elicited endocytosis. J. Biol. Chem. 274:1999;24935-24940.
5. 2A-adrenergic receptor imparts enhanced agonist-promoted Gi coupling. J. Biol. Chem. 275:2000;38518-38523.
6. 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J. Biol. Chem. 276:2001;4917-4922.
7. 2C-adrenergic receptor confers impaired coupling to multiple effectors. J. Biol. Chem. 275:2000;23059-23064.
8. 2-adrenergic receptor subtype, the gene for which is located on chromosome 2. Proc. Natl. Acad. Sci. U.S.A. 87:1990;5094-5098.
9. 2B- adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 87:1990;3102-3106.
10. 2A-adrenergic receptor knockout mice. Mol. Pharmacol. 56:1999;154-161.
11. 2A-adrenergic receptor subtype. Science. 273:1996;801-803.
12. 2C2 mRNA in multiple tissues. Mol. Pharmacol. 44:1993;70-75.
13. 2-adrenergic receptor subtypes in human tissues. Evidence for species heterogeneity and implications for human pharmacology. Anesthesiology. 81:1994;1235-1244.
14. 2A-selective compound Eur. J. Pharmacol. 202:1991;235-243.
15. 2B-subtype expression in haematopoietic cells of the erythrocyte lineage. Br. J. Pharmacol. 133:2001;1387-1395.
16. 2A-adrenergic receptor gene. J. Biol. Chem. 267:1992;24017-24022.
17. 2A-adrenergic receptor gene overlaps an Sp1 consensus binding site. Biochem. J. 311:1995;541-547.
18. 2C-adrenergic receptor gene promoter and its cell-type-specific activity. Mol. Pharmacol. 50:1996;1432-1442.
19. Schaak S., Devedjian J.C., Cayla C., Sender Y., Paris H. Molecular cloning, sequencing and functional study of the promoter region of the human α2C4-adrenergic receptor gene. Biochem. J. 328:1997;431-438.
20. 2C2 adrenoceptor subtype gene. Neurosci. Lett. 210:1996;33-36.
21. 2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J. Clin. Endocrinol. Metab. 84:1999;2429-2433.
22. Solovyev V., Salamov A. The Gene-Finder computer tools for analysis of human and model organisms genome sequences. Proc. Int. Conf. Intell. Syst. Mol. Biol. 5:1997;294-302.
23. 2C subtype. J. Pharmacol. Exp. Ther. 281:1997;983-991.
24. Blume S.W., Snyder R.C., Ray R., Thomas S., Koller C.A., Miller D.M. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J. Clin. Invest. 88:1991;1613-1621.
25. Tatusova T.A., Madden T.L. BLAST 2 sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol. Lett. 174:1999;247-250.
26. 2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J. Am. Coll. Cardiol. 37:2001;1516-1522.
27. 2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death. J. Am. Coll. Cardiol. 41:2003;190-194.
28. 2B-adrenergic receptor and lack of linkage with essential hypertension. Am. J. Hypertens. 12:1999;853-857.
29. 2-adrenoreceptors on haemodynamic responses to adrenaline. Clin. Sci. (Lond.). 104:2003;509-520.
30. 2A-adrenergic receptor gene. Hypertension. 27:1996;1018-1024.